BlackRock Fund Advisors - CTI BIOPHARMA CORP ownership

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q4 2016$22,000
+37.5%
52,768
+25.1%
0.00%
Q3 2016$16,000
-40.7%
42,164
-47.3%
0.00%
Q2 2016$27,000
-99.2%
80,061
-98.7%
0.00%
-100.0%
Q1 2016$3,212,000
-54.7%
6,043,618
+4.8%
0.00%
-50.0%
Q4 2015$7,092,000
+13.2%
5,766,088
+34.4%
0.00%0.0%
Q3 2015$6,264,000
-24.2%
4,290,232
+1.2%
0.00%0.0%
Q2 2015$8,268,000
+8.8%
4,239,943
+1.0%
0.00%0.0%
Q1 2015$7,598,000
-22.7%
4,197,699
+0.8%
0.00%0.0%
Q4 2014$9,827,000
+24.8%
4,163,937
+28.0%
0.00%0.0%
Q3 2014$7,872,000
-16.5%
3,252,712
-3.1%
0.00%
-33.3%
Q2 2014$9,429,0003,355,5860.00%
Other shareholders

There were no reported owners of CTI BIOPHARMA CORP in Q3 2023.

NameSharesValueWeighting ↓
View complete list of CTI BIOPHARMA CORP shareholders